Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells.

scientific article published on January 2011

Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1042/BJ20101104
P698PubMed publication ID20958264

P50authorSahng Wook ParkQ60981161
Mijin YunQ61151102
P2093author name stringHyo-Jeong Kim
Jae-Woo Kim
Jong-Seok Moon
Kyung-Sup Kim
Won-Ji Jin
Jin-Hye Kwak
P2860cites workHigh aerobic glycolysis of rat hepatoma cells in culture: Role of mitochondrial hexokinaseQ24561487
Glucose catabolism in cancer cells. Isolation, sequence, and activity of the promoter for type II hexokinaseQ28115329
Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3)Q28138539
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase: a metabolic signaling enzymeQ28290284
Androgen receptor in prostate cancerQ29616454
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.Q31879172
Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B.Q33179024
PTEN, a unique tumor suppressor geneQ33974014
Multiple forms of hexokinase in the rat: tissue distribution, age dependency, and propertiesQ34053490
Positron-emission tomography with [18F]fluorodeoxyglucose. Part I. Biochemical uptake mechanism and its implication for clinical studiesQ34067149
Hypoxia induces transcription of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-4 gene via hypoxia-inducible factor-1alpha activationQ34357440
Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors.Q34422480
Androgen receptors in prostate cancerQ34866937
Androgens, lipogenesis and prostate cancer.Q36017037
Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteinsQ36714297
KLF5 enhances SREBP-1 action in androgen-dependent induction of fatty acid synthase in prostate cancer cells.Q38287719
Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II geneQ38355181
Androgen-dependent activation of human cytomegalovirus major immediate-early promoter in prostate cancer cells.Q38499941
Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancerQ40382360
Remarkably enhanced expression of the type II hexokinase in rat hepatoma cell line AH130.Q41661472
Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.Q43298914
FDG PET for evaluating the change of glucose metabolism in prostate cancer after androgen ablation.Q43707212
Glucose metabolism in cancer: importance of transcription factor-DNA interactions within a short segment of the proximal region og the type II hexokinase promoterQ44534309
Phosphorylation and Activation of Heart 6-Phosphofructo-2-kinase by Protein Kinase B and Other Protein Kinases of the Insulin Signaling CascadesQ57800756
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectprostate cancerQ181257
P1104number of pages9
P304page(s)225-233
P577publication date2011-01-01
P1433published inBiochemical JournalQ864221
P1476titleAndrogen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells
P478volume433

Reverse relations

cites work (P2860)
Q905561786-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer
Q39124486A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancer.
Q45169319Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis
Q39795284Akt-dependent activation of the heart 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB2) isoenzyme by amino acids.
Q37610799Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies
Q53476667Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes.
Q39067480Androgens regulate prostate cancer cell growth via an AMPK-PGC-1α-mediated metabolic switch.
Q38166477Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism
Q37564733Caveolin-1 regulates hormone resistance through lipid synthesis, creating novel therapeutic opportunities for castration-resistant prostate cancer
Q53699332Delineation of the androgen-regulated signaling pathways in prostate cancer facilitates the development of novel therapeutic approaches.
Q39512219Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
Q49307514Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
Q64271866Effect of PTEN loss on metabolic reprogramming in prostate cancer cells
Q39200208Excess glucose induces hypoxia-inducible factor-1α in pancreatic cancer cells and stimulates glucose metabolism and cell migration
Q43139072Fatty acid synthesis and NLRP3-inflammasome
Q58764753Fructose 2,6-Bisphosphate in Cancer Cell Metabolism
Q34274098Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Q50066658GLUT12 promotes prostate cancer cell growth and is regulated by androgens and CaMKK2 signaling.
Q37014362Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet
Q47977198Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1α and Ki-67.
Q36681426Hexokinase is a key regulator of energy metabolism and ROS activity in insect lifespan extension
Q28393898Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells
Q34035683Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations
Q42118494Incidental detection of prostate-specific antigen-negative metastatic prostate cancer initially presented with solitary pulmonary nodule on fluorodeoxyglucose positron emission tomography/computed tomography
Q38737293Kallikrein-related peptidases (KLKs) and the hallmarks of cancer
Q38002682Lipids and prostate cancer
Q92073772LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells
Q27014979Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Q90642651Metabolic Plasticity in Chemotherapy Resistance
Q38936250Metabolic Reprogramming by the PI3K-Akt-mTOR Pathway in Cancer.
Q39095849Metabolic alterations during the growth of tumour spheroids
Q54350939Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status.
Q34749943N-linked glycosylation supports cross-talk between receptor tyrosine kinases and androgen receptor
Q34336533PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli
Q41126547PFKL/miR-128 axis regulates glycolysis by inhibiting AKT phosphorylation and predicts poor survival in lung cancer
Q60921025PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia (Review)
Q51357703Phosphofructokinase-P Modulates P44/42 MAPK Levels in HeLa Cells.
Q92410918Prostate Cancer Energetics and Biosynthesis
Q37537958Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
Q38616121Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression
Q52663598SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway.
Q92522698Synergistic combination of DT-13 and Topotecan inhibits aerobic glycolysis in human gastric carcinoma BGC-823 cells via NM IIA/EGFR/HK II axis
Q38132274Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy
Q38323902Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer
Q47379977The dark side of glucose transporters in prostate cancer: Are they a new feature to characterize carcinomas?
Q38096735The fat side of prostate cancer
Q89948640Tumour metabolism and its unique properties in prostate adenocarcinoma
Q55058557UAP1 is overexpressed in prostate cancer and is protective against inhibitors of N-linked glycosylation.
Q33647013Vitamin D, intermediary metabolism and prostate cancer tumor progression

Search more.